Alpha Teknova, Inc. (TKNO): Cash & Equivalents
$5.91M
As of 2025-12-31
$6.00M
As of 2026-06-30
-48.1%
3-year compound annual growth
+12.3%
5-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.91M | +59.4% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $3.71M | -87.0% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $28.48M | -32.6% | 2025-03-07, Balance as of period end |
| 2022-12-31 | $42.24M | -51.7% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $87.52M | n/m | 2022-03-18, Balance as of period end |
| 2020-12-31 | $3.31M | n/a | 2022-03-18, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $5.91M | +59.4% |
| Immucell Corp (ICCC) | 2025-12-31 | $3.81M | +1.3% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $155.46M | -17.8% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $1.75M | -0.8% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $7.77M | -34.0% |
| Biomerica Inc (BMRA) | 2026-05-31 | $1.31M | -45.5% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $11.58M | +34.1% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $149.60M | +46.1% |
| Neogen Corp (NEOG) | 2026-05-31 | $185.50M | +43.8% |
Compare TKNO, ICCC, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗